Bioinvent International Ab
Clinical trials sponsored by Bioinvent International Ab, explained in plain language.
-
New combo therapy aims to reboot immune attack on Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental drug called BI-1206 combined with the immunotherapy pembrolizumab in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to find a safe dose and see if the combination can help the immune system fight…
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated May 17, 2026 02:08 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called BI-1808, alone or with another drug (pembrolizumab), in people with advanced cancers (like ovarian cancer, melanoma, or T-cell lymphoma) that have not responded to standard treatments. The main goals are to check safety, find the bes…
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated May 13, 2026 15:59 UTC